A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
08/2011
08/30/2011	US8007781 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
08/30/2011	CA2489259C Polymeric micelle complexes of low molecular weight antitumor agents and styrene maleic acid copolymers
08/30/2011	CA2468965C Use of anastrozole for the treatment of post-menopausal women having early breast cancer
08/30/2011	CA2440473C Metalloproteinase inhibitors
08/30/2011	CA2436407C Polymer conjugates of neublastin and methods of using same
08/30/2011	CA2406392C Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
08/30/2011	CA2405458C Herpes viruses for immune modulation
08/30/2011	CA2393352C Adamantane derivatives
08/30/2011	CA2372150C Therapeutic applications of pro-apoptotic benzodiazepines
08/30/2011	CA2362268C Novel substance derived from basidiomycetes culture, method for producing it and its use
08/30/2011	CA2331329C Diacylglycerol acyl transferase proteins
08/30/2011	CA2288962C Human monoclonal antibodies to epidermal growth factor receptor
08/30/2011	CA2283630C Ligand/lytic peptide compositions and methods of use
08/25/2011	WO2011103586A2 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine
08/25/2011	WO2011103509A1 Heterocyclic compounds and uses as anticancer agents
08/25/2011	WO2011103423A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	WO2011103413A2 Taxane pro-emulsion formulations and methods making and using the same
08/25/2011	WO2011103345A2 Methods and compositions for influencing tumors using microrna-185 as a tumor suppressor
08/25/2011	WO2011103289A2 Imidazole-2, 4-dione inhibitors of casein kinase 1
08/25/2011	WO2011103242A1 Neuregulin antagonists and use thereof in treating cancer
08/25/2011	WO2011103175A2 Oxysterols that activate liver x receptor signaling and inhibit hedgehog signaling
08/25/2011	WO2011103028A2 Compositions and methods for inhibiting mmset
08/25/2011	WO2011103016A2 Compositions and methods for inhibiting ezh2
08/25/2011	WO2011103011A2 Gene fusion targeted therapy
08/25/2011	WO2011103007A2 10'-fluorinated vinca alkaloids provide enhanced biological activity against mdr cancer cells
08/25/2011	WO2011102999A2 Spink1 targeted therapy
08/25/2011	WO2011102660A2 A novel 5-membered heterocycle derivatives and manufacturing process thereof
08/25/2011	WO2011102626A2 Polyazamacrocyclic compound, and a production method and a biomedical use therefor
08/25/2011	WO2011102436A1 Tgf-β signal transduction inhibitor
08/25/2011	WO2011102414A1 Oligonucleotide derivative
08/25/2011	WO2011102407A1 Radiation therapy agent
08/25/2011	WO2011102404A1 Imidazole derivative
08/25/2011	WO2011102399A1 Heterocyclic compound
08/25/2011	WO2011101912A1 Recombinant herpes virus and pharmaceutical composition containing recombinant herpes virus
08/25/2011	WO2011101806A1 Bicyclic compounds and their uses as dual c-src / jak inhibitors
08/25/2011	WO2011101804A1 Pyrazolo piperidine derivatives as nadph oxidase inhibitors
08/25/2011	WO2011101787A1 Non peptidic 14-3-3 inhibitors and the use thereof
08/25/2011	WO2011101644A1 Triazolo [4, 5 - b] pyridin derivatives
08/25/2011	WO2011101643A1 Compositions comprising perfluorooctanoic acid
08/25/2011	WO2011101429A1 Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
08/25/2011	WO2011101417A1 Deuterated pyrrolopyrimidine compounds as inhibitors of cdk4/6
08/25/2011	WO2011101409A1 Pyrrolopyrimidine compounds as inhibitors of cdk4/6
08/25/2011	WO2011101408A1 Method for preventing cancer metastasis
08/25/2011	WO2011101369A1 Dihydropteridinones, method for production and use thereof
08/25/2011	WO2011101297A1 Substituted spiroindolinones
08/25/2011	WO2011101161A1 Pyrazole derivatives as jak inhibitors
08/25/2011	WO2011100983A1 Casein, a novel curcumin drug carrier system
08/25/2011	WO2011100840A1 Substituted 2-imidazolidones and analogs
08/25/2011	WO2011063156A3 Acid salt forms of polymer-drug conjugates and alkoxylation methods
08/25/2011	WO2011055215A3 Novel benzopyran kinase modulators
08/25/2011	WO2011052883A3 Method for activating a natural killer cell by adjusting the expression of the socs2 gene
08/25/2011	WO2011050302A3 Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment
08/25/2011	WO2011047384A9 Methods of inhibiting ire1
08/25/2011	WO2011046599A9 Treatment and prognosis with thalidomide in multiple myeloma based on karyotyping and gene expression profiling
08/25/2011	WO2011044587A3 Cytoprotective or therapeutic plant composition
08/25/2011	WO2011041461A3 Polycyclic compounds as lysophosphatidic acid receptor antagonists
08/25/2011	WO2011032161A3 Vaccines directed to langerhans cells
08/25/2011	WO2011031890A3 Cancer stem cell-targeted and drug resistant cancer therapy
08/25/2011	WO2011026912A3 Retinoic acid receptor antagonists, mir-10a inhibitors and inhibitors of hoxb1 or hoxb3 repressors for treating pancreatic cancer
08/25/2011	WO2011013912A3 Pharmaceutical composition for enhancing radiation therapy for cancer, and method for screening active material for enhancing radiation therapy for cancer
08/25/2011	WO2011011522A3 Potent small molecule inhibitors of autophagy, and methods of use thereof
08/25/2011	WO2010150211A3 Use of derivatives of indoles for the treatment of cancer
08/25/2011	WO2010149688A3 Antitumoral compounds
08/25/2011	US20110207814 Combination Therapy for Breast Cancer Treatment
08/25/2011	US20110207810 N1-benzo[1,3]dioxol-5-ylmethyl-n2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing same
08/25/2011	US20110207808 Long-chain carboxychromanols and analogs for use as anti-inflammatory agents
08/25/2011	US20110207805 Composition of flavanolignan and amino acid with improved water solubility
08/25/2011	US20110207804 Compositions for the treatment of neoplastic diseases
08/25/2011	US20110207803 Taxane Pro-Emulsion Formulations and Methods Making and Using the Same
08/25/2011	US20110207799 Compositions for Targeted Delivery of siRNA
08/25/2011	US20110207798 Method for treating breast cancer using adenine nucleotide translocator 2 (ant2) sirna or ant2 shrna
08/25/2011	US20110207789 Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
08/25/2011	US20110207774 Triazolothiadiazole inhibitor of c-met protein kinase
08/25/2011	US20110207767 Novel cc-1065 Analogs and Their Conjugates
08/25/2011	US20110207764 Cyclopolysaccharide compositions
08/25/2011	US20110207760 Sn-38 compositions
08/25/2011	US20110207757 Tricyclic Compounds Having Cytostatic and/or Cytoxic Activity and Methods of Use Thereof
08/25/2011	US20110207756 Antitumor agent for thyroid cancer
08/25/2011	US20110207754 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	US20110207752 P70 s6 kinase inhibitor and egfr inhibitor combination therapy
08/25/2011	US20110207751 Heterocyclic compounds and uses as anticancer agents
08/25/2011	US20110207743 Pyrazolylaminopyridines as inhibitors of fak
08/25/2011	US20110207739 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof
08/25/2011	US20110207736 Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
08/25/2011	US20110207732 Azaindole derivatives
08/25/2011	US20110207731 Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof
08/25/2011	US20110207727 Thio-subsituted Anthra [1, 2-d] imidazole- 6, 11-dione Dervatives, Preparation Method and application thereof
08/25/2011	US20110207726 Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S
08/25/2011	US20110207725 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
08/25/2011	US20110207720 Quinolin-4-one and 4-oxodihyrdocinnoline derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
08/25/2011	US20110207719 Novel Anthra [1, 2-d]imidazole-6,11-dione Derivatives, Preparation Method and application thereof
08/25/2011	US20110207716 Inhibitors of polo-like kinase
08/25/2011	US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/25/2011	US20110207712 Phosphatidylinositol 3-Kinase Inhibitors And Methods Of Their Use
08/25/2011	US20110207711 Therapeutic Compounds
08/25/2011	US20110207705 Oviedomycin derivatives, method for obtaining same and use thereof
08/25/2011	US20110207692 Combinations of sapacitabine or cndac with dna methyltransferase inhibitors such as decitabine and procaine
08/25/2011	US20110207691 Cobalamin compositions for the treatment of cancer
08/25/2011	US20110207686 Polysaccharide-and polypeptide-based block copolymers, vesicles constituted by these copolymers and use thereof
08/25/2011	US20110207685 Oral Formulations of Chemotherapeutic Agents

1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 2211